It has been reported that TXNIP is an important mediator for NLRP3 inflammasome activation, emerged as a target in multiple diseases, including cervical inflammation, diabetic nephropathy, and tubular injury [24–26]. The gene discussed is TXNIP; the disease is diabetic kidney disease.